ID23673A - Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat - Google Patents

Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat

Info

Publication number
ID23673A
ID23673A IDW990859D ID990859D ID23673A ID 23673 A ID23673 A ID 23673A ID W990859 D IDW990859 D ID W990859D ID 990859 D ID990859 D ID 990859D ID 23673 A ID23673 A ID 23673A
Authority
ID
Indonesia
Prior art keywords
klavulanat
amoxicilin
pharmaceutical formulation
formulation consist
consist
Prior art date
Application number
IDW990859D
Other languages
English (en)
Inventor
Jacky Andre Gustave Mention
Jose Luis Sanroma Bordallo
Kevin Huntley Storm
Original Assignee
Smithkline Beecham Lab Pharma
Smithkline Beecham Sa
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703100.9A external-priority patent/GB9703100D0/en
Priority claimed from GBGB9703099.3A external-priority patent/GB9703099D0/en
Priority claimed from GBGB9703101.7A external-priority patent/GB9703101D0/en
Application filed by Smithkline Beecham Lab Pharma, Smithkline Beecham Sa, Smithkline Beecham Corp filed Critical Smithkline Beecham Lab Pharma
Publication of ID23673A publication Critical patent/ID23673A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
IDW990859D 1997-02-14 1998-02-10 Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat ID23673A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703100.9A GB9703100D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703099.3A GB9703099D0 (en) 1997-02-14 1997-02-14 Formulations
GBGB9703101.7A GB9703101D0 (en) 1997-02-14 1997-02-14 Formulations

Publications (1)

Publication Number Publication Date
ID23673A true ID23673A (id) 2000-05-11

Family

ID=27268719

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990859D ID23673A (id) 1997-02-14 1998-02-10 Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat

Country Status (25)

Country Link
EP (2) EP0975342B1 (id)
JP (1) JP2001512451A (id)
KR (1) KR100499812B1 (id)
CN (1) CN1194687C (id)
AP (1) AP1253A (id)
AT (1) ATE243516T1 (id)
AU (1) AU728526B2 (id)
BG (1) BG103664A (id)
BR (1) BR9807383A (id)
CA (1) CA2280857A1 (id)
DE (1) DE69815833T2 (id)
DZ (1) DZ2420A1 (id)
EA (1) EA002595B1 (id)
ES (1) ES2201468T3 (id)
HK (1) HK1043041A1 (id)
ID (1) ID23673A (id)
IL (1) IL131201A (id)
MA (1) MA24473A1 (id)
NO (1) NO993887D0 (id)
NZ (1) NZ337043A (id)
OA (1) OA11087A (id)
PL (1) PL334976A1 (id)
SK (1) SK110299A3 (id)
TR (1) TR199901961T2 (id)
WO (1) WO1998035672A1 (id)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
JP3501289B2 (ja) 1995-09-07 2004-03-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 医薬処方
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
AU2869100A (en) * 1999-02-26 2000-09-14 Biovail International Ltd. Storage stable amoxycillin and clavulanate suspension composition
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
ITMI20000788A1 (it) * 1999-04-13 2001-10-11 Beecham Pharmaceuticals Pte Li Nuovo metodo di trattamento
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
AU6571400A (en) 1999-08-20 2001-03-19 Smithkline Beecham Laboratoires Pharmaceutiques S.A.S. Pharmaceutical formulation comprising amoxycillin and clavulanate
FR2797588B1 (fr) * 1999-08-20 2003-08-01 Smithkline Beecham Lab Formulation pharmaceutique a base d'amoxycilline et de clavulanate
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AT412344B (de) * 2001-04-12 2005-01-25 Sandoz Ag Hydrophobisierte teilchen von k-clavulanat
AT413983B (de) * 2001-04-12 2006-08-15 Sandoz Ag K-clavulanat in der form eines granulates
EP1474104A2 (en) * 2002-02-01 2004-11-10 Sandoz Ag Demixing-stable granulate
US20060110445A1 (en) * 2002-07-16 2006-05-25 Shashikanth Isloor Dispersible tablet for oral administration
JP2006527726A (ja) * 2003-06-16 2006-12-07 グラクソ　グループ　リミテッド アモキシシリンおよびクラブラン酸塩を含む医薬製剤
WO2005123041A1 (en) * 2004-06-18 2005-12-29 Yuhan Corporation Oral dispersible tablet composition of amoxycillin and/or clavulanic acid comprising a surface-modified sodium bicarbonate
SI21912A (sl) * 2004-12-24 2006-06-30 Lek Farmacevtska Druzba D.D. Stabilne farmacevtske oblike, ki vsebujejo amoksicilin in klavulansko kislino
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN100464750C (zh) * 2006-02-23 2009-03-04 珠海联邦制药股份有限公司 一种制备含阿莫西林钠和克拉维酸钾的药物混合物的方法
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20080352A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
CA2723409C (en) 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014065769A1 (en) * 2012-10-22 2014-05-01 Bilgiç Mahmut Formulations for oral suspensions comprising antibiotics
PL3046548T3 (pl) * 2013-09-20 2020-07-13 Centrient Pharmaceuticals Netherlands B.V. Tabletka zawierająca krospowidon
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
EP3994154A1 (en) 2019-07-05 2022-05-11 GlaxoSmithKline Intellectual Property (No.2) Limited Streptomyces clavuligerus
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法
CN114869884A (zh) * 2021-07-30 2022-08-09 江苏恒丰强生物技术有限公司 一种用于猪呼吸道疾病的复方阿莫西林粉及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
WO1994016696A1 (en) * 1993-01-22 1994-08-04 Smithkline Beecham Plc Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.

Also Published As

Publication number Publication date
KR100499812B1 (ko) 2005-07-08
PL334976A1 (en) 2000-03-27
EP1142574A1 (en) 2001-10-10
NZ337043A (en) 2001-02-23
OA11087A (en) 2003-03-13
AP1253A (en) 2004-03-17
ATE243516T1 (de) 2003-07-15
KR20000071076A (ko) 2000-11-25
MA24473A1 (fr) 1998-10-01
EA002595B1 (ru) 2002-06-27
DE69815833D1 (de) 2003-07-31
DZ2420A1 (fr) 2003-01-04
JP2001512451A (ja) 2001-08-21
NO993887L (no) 1999-08-12
EA199900647A1 (ru) 2000-06-26
WO1998035672A1 (en) 1998-08-20
IL131201A0 (en) 2001-01-28
DE69815833T2 (de) 2004-05-19
HK1043041A1 (zh) 2002-09-06
CN1194687C (zh) 2005-03-30
CN1251990A (zh) 2000-05-03
AU6719698A (en) 1998-09-08
ES2201468T3 (es) 2004-03-16
EP0975342B1 (en) 2003-06-25
AP9901623A0 (en) 1999-09-30
IL131201A (en) 2005-06-19
NO993887D0 (no) 1999-08-12
AU728526B2 (en) 2001-01-11
EP0975342A1 (en) 2000-02-02
SK110299A3 (en) 2000-08-14
CA2280857A1 (en) 1998-08-20
BR9807383A (pt) 2000-03-14
TR199901961T2 (xx) 1999-11-22
BG103664A (en) 2000-03-31

Similar Documents

Publication Publication Date Title
ID23673A (id) Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
ID21683A (id) Komposisi farmasi padat yang terdiri dari siklosporin dan bahan permukaan anionik
ID28270A (id) Komposisi dan formulasi peptida dan penggunaannya
EG24044A (en) pharmaceutical formulation of omeprazole
PT1041972E (pt) Comprimido para a libertacao instantanea e prolongada de uma ou mais substancias activas
ID24202A (id) Multi-fase agregat yang terdiri dari karbon dan preparasinya
BR9706311A (pt) Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ID21806A (id) Bentuk penakaran farmasi yang secara cepat dilepaskan dan yang menutup rasa
ID26945A (id) Komposisi farmasi yang mengandung misel yang terdiri dari glukokortikosteroid lipofilik dan hanya satu surfaktan
ID22523A (id) Formulasi aerosol obat yang mengandung budesonida
ID17407A (id) Formulasi kosmetik dan/atau farmasi
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
HUP9902655A3 (en) Pharmaceutical composition of hedgehog proteins and use thereof
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
HK1015351A1 (en) Substituted amino compounds and their use as analgesic active substances
NO981166D0 (no) Fremstilling av askorbylmonofosfater
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
ID26955A (id) Komposisi farmasi homogen yang terdiri dari abacavir, lamivudin dan zidovudin
ID21764A (id) Komposisi-komposisi yang mengandung antijamur dan fosfolipid
FI965204A0 (fi) Bromelaiinin lääkekäyttö
BR9708790A (pt) Composto uso de um composto e formulação farmacêutica
HUP0001858A3 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ID22416A (id) Komposisi-komposisi farmasi yang mengandung ibuprofen dan domperidon untuk pengobatan migrain